Table 1.
Demographic and clinical data of the study group
| |
Patients (n=393) |
Controls (n=434) |
Pa |
|---|---|---|---|
| No. (%) | No. (%) | ||
| Age |
|
|
|
| ≤35 |
82 (20.9) |
105 (24.4) |
0.377 |
| 36-50 |
219 (55.7) |
241 (55.5) |
|
| >50 |
92 (23.4) |
88 (20.3) |
|
| Smoking |
|
|
|
| Never |
371 (94.4) |
419 (96.5) |
0.177 |
| Ever |
22 (5.6) |
15 (3.5) |
|
| HPV status |
|
|
|
| HPV+ |
351 (89.3) |
0 (0) |
|
| HPV- |
42 (10.7) |
434 (100) |
|
| Clinical stageb |
|
|
|
| Stage 0 |
213 (54.2) |
|
|
| Stage I |
138 (35.1) |
|
|
| Stage II |
34 (8.7) |
|
|
| Stage III |
7 (1.8) |
|
|
| Stage IV | 1 (0.3) |